Tara I. Chang

Nephrologist - Kidney specialist

Refractory hypertension specialist, Chronic kidney disease specialist, End stage renal disease specialist

Kidney Clinic (Nephrology)

  • 300 Pasteur Drive
  • Stanford, CA 94305
  • Phone: 650-723-6961
Learn More About the Clinic Getting Here Make An Appointment

Professional Education

Fellowship: Stanford University - CAPS (2009) CA

Board Certification: Nephrology, American Board of Internal Medicine (2009)

Board Certification: Internal Medicine, American Board of Internal Medicine (2006)

Residency: UCSF-Graduate Medical Education (2006) CA

Internship: UCSF-Internal Medicine (2004) CA

Medical Education: University of Michigan Health System (2003) MI

Comparative effectiveness of coronary artery bypass grafting and percutaneous coronary intervention for multivessel coronary disease in a community-based population with chronic kidney disease.
Chang, T. I., Leong, T. K., Kazi, D. S., Lee, H. S., Hlatky, M. A., & Go, A. S. (2013). Comparative effectiveness of coronary artery bypass grafting and percutaneous coronary intervention for multivessel coronary disease in a community-based population with chronic kidney disease. American heart journal, 165(5), 800-808 e2.

Visit-to-visit systolic blood pressure variability and outcomes in hemodialysis.
Chang, T. I., Flythe, J. E., Brunelli, S. M., Muntner, P., Greene, T., & Chertow, G. M. (2013). Visit-to-visit systolic blood pressure variability and outcomes in hemodialysis. Journal of human hypertension.

Multivessel Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention in ESRD
Chang, T. I., Shilane, D., Kazi, D. S., Montez-Rath, M. E., Hlatky, M. A., & Winkelmayer, W. C. (2012). Multivessel Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention in ESRD. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 23(12), 2042-2049.

Comparative Effectiveness of Clopidogrel in Medically Managed Patients With Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction.
Solomon, M. D., Go, A. S., Shilane, D., Boothroyd, D. B., Leong, T. K., & Hlatky, M. A. (2014). Comparative Effectiveness of Clopidogrel in Medically Managed Patients With Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction. Journal of the American College of Cardiology, 63(21), 2249-2257.

Near-Term Prediction of Sudden Cardiac Death in Older Hemodialysis Patients Using Electronic Health Records
Goldstein, B. A., Chang, T. I., Mitani, A. A., Assimes, T. L., & Winkelmayer, W. C. (2014). Near-Term Prediction of Sudden Cardiac Death in Older Hemodialysis Patients Using Electronic Health Records. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 9(1), 82-91.

Incremental prognostic information from kidney function in patients with new onset coronary heart disease
Hlatky, M. A., Shilane, D., Chang, T. I., Boothroyd, D., & Go, A. S. (2014). Incremental prognostic information from kidney function in patients with new onset coronary heart disease. AMERICAN HEART JOURNAL, 167(1), 86-92.

Multivessel coronary revascularization and outcomes in kidney transplant recipients.
Lenihan, C. R., Montez-Rath, M. E., Winkelmayer, W. C., & Chang, T. I. (2013). Multivessel coronary revascularization and outcomes in kidney transplant recipients. Transplant international , 26(11), 1080-1087.

Use and safety of heparin-free maintenance hemodialysis in the USA
Shen, J. I., Mitani, A. A., Chang, T. I., & Winkelmayer, W. C. (2013). Use and safety of heparin-free maintenance hemodialysis in the USA. NEPHROLOGY DIALYSIS TRANSPLANTATION, 28(6), 1589-1602.

Comparative effectiveness of multivessel coronary bypass surgery and multivessel percutaneous coronary intervention: a cohort study.
Hlatky, M. A., Boothroyd, D. B., Baker, L., Kazi, D. S., Solomon, M. D., & Go, A. S. (2013). Comparative effectiveness of multivessel coronary bypass surgery and multivessel percutaneous coronary intervention: a cohort study. Annals of internal medicine, 158(10), 727-734.

Risk Factors for ESRD in Individuals With Preserved Estimated GFR With and Without Albuminuria: Results From the Kidney Early Evaluation Program (KEEP)
Chang, T. I., Li, S., Chen, S.-C., Peralta, C. A., Shlipak, M. G., & Tamura, M. K. (2013). Risk Factors for ESRD in Individuals With Preserved Estimated GFR With and Without Albuminuria: Results From the Kidney Early Evaluation Program (KEEP). AMERICAN JOURNAL OF KIDNEY DISEASES, 61(4), S4-S11.

Effectiveness of beta-Blockers in Heart Failure With Left Ventricular Systolic Dysfunction and Chronic Kidney Disease
Chang, T. I., Yang, J., Freeman, J. V., Hlatky, M. A., & Go, A. S. (2013). Effectiveness of beta-Blockers in Heart Failure With Left Ventricular Systolic Dysfunction and Chronic Kidney Disease. JOURNAL OF CARDIAC FAILURE, 19(3), 176-182.

Comparative Effectiveness Research in Heart Failure Therapies Women, Elderly Patients, and Patients with Kidney Disease
Shah, R. U., Chang, T. I., & Fonarow, G. C. (2013). Comparative Effectiveness Research in Heart Failure Therapies Women, Elderly Patients, and Patients with Kidney Disease. HEART FAILURE CLINICS, 9(1), 79-?.

Comparative effectiveness research: what is it and why do we need it in nephrology?
Chang, T. I., & Winkelmayer, W. C. (2012). Comparative effectiveness research: what is it and why do we need it in nephrology?. NEPHROLOGY DIALYSIS TRANSPLANTATION, 27(6), 2156-2161.

Use of Secondary Prevention Medications among Adults with Reduced Kidney Function
Chang, T. I., Gao, L., Brown, T. M., Safford, M. M., Judd, S. E., & Winkelmayer, W. C. (2012). Use of Secondary Prevention Medications among Adults with Reduced Kidney Function. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 7(4), 604-611.

Blood Pressure Components and End-stage Renal Disease in Persons With Chronic Kidney Disease The Kidney Early Evaluation Program (KEEP)
Peralta, C. A., Norris, K. C., Li, S., Chang, T. I., Tamura, M. K., & Shlipak, M. (2012). Blood Pressure Components and End-stage Renal Disease in Persons With Chronic Kidney Disease The Kidney Early Evaluation Program (KEEP). ARCHIVES OF INTERNAL MEDICINE, 172(1), 41-47.

Chronic Kidney Disease and Cardiovascular Therapeutics Time to Close the Evidence Gaps
Chang, T. I., & Chertow, G. M. (2011). Chronic Kidney Disease and Cardiovascular Therapeutics Time to Close the Evidence Gaps. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 58(11), 1162-1164.

Angiotensin-converting enzyme inhibitors and cardiovascular outcomes in patients on maintenance hemodialysis
Chang, T. I., Shilane, D., Brunelli, S. M., Cheung, A. K., Chertow, G. M., & Winkelmayer, W. C. (2011). Angiotensin-converting enzyme inhibitors and cardiovascular outcomes in patients on maintenance hemodialysis. AMERICAN HEART JOURNAL, 162(2), 324-330.

Intradialytic Hypotension and Vascular Access Thrombosis
Chang, T. I., Paik, J., Greene, T., Desai, M., Bech, F., & Chertow, G. M. (2011). Intradialytic Hypotension and Vascular Access Thrombosis. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 22(8), 1526-1533.

Kidney Function and Long-Term Medication Adherence after Myocardial Infarction in the Elderly
Chang, T. I., Desai, M., Solomon, D. H., & Winkelmayer, W. C. (2011). Kidney Function and Long-Term Medication Adherence after Myocardial Infarction in the Elderly. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 6(4), 864-869.

Systolic blood pressure and mortality in prevalent haemodialysis patients in the HEMO study
Chang, T. I., Friedman, G. D., Cheung, A. K., Greene, T., Desai, M., & Chertow, G. M. (2011). Systolic blood pressure and mortality in prevalent haemodialysis patients in the HEMO study. JOURNAL OF HUMAN HYPERTENSION, 25(2), 98-105.

Blood Pressure Control in Type 2 Diabetes Mellitus
Chang, T. I., Cheung, A. K., & Chertow, G. M. (2010). Blood Pressure Control in Type 2 Diabetes Mellitus. AMERICAN JOURNAL OF KIDNEY DISEASES, 56(6), 1029-1031.

Updated comorbidity assessments and outcomes in prevalent hemodialysis patients
Chang, T. I., Paik, J., Greene, T., Miskulin, D. C., & Chertow, G. M. (2010). Updated comorbidity assessments and outcomes in prevalent hemodialysis patients. HEMODIALYSIS INTERNATIONAL, 14(4), 478-485.

Kidney Disease and Antihypertensive Medication Adherence: The Need for Improved Measurement Tools
Chang, T. I., & Winkelmayer, W. C. (2010). Kidney Disease and Antihypertensive Medication Adherence: The Need for Improved Measurement Tools. AMERICAN JOURNAL OF KIDNEY DISEASES, 56(3), 423-426.

Kidney Disease, Hospitalized Hypertension, and Cardiovascular Events: Cause or Consequence?
Chertow, G. M., & Chang, T. I. (2010). Kidney Disease, Hospitalized Hypertension, and Cardiovascular Events: Cause or Consequence?. CIRCULATION, 121(20), 2160-2161.

GFR estimating equations, CKD prevalence and the public health
Chang, T. I., & Chertow, G. M. (2010). GFR estimating equations, CKD prevalence and the public health. JOURNAL OF INTERNAL MEDICINE, 267(4), 354-356.

Oxidant regulation of gene expression and neural tube development: Insights gained from diabetic pregnancy on molecular causes of neural tube defects
Chang, T. I., Horal, M., Jain, S. K., Wang, F., Patel, R., & Loeken, M. R. (2003). Oxidant regulation of gene expression and neural tube development: Insights gained from diabetic pregnancy on molecular causes of neural tube defects. DIABETOLOGIA, 46(4), 538-545.

Evidence that elevated glucose causes altered gene expression, apoptosis, and neural tube defects in a mouse model of diabetic pregnancy
Fine, E. L., Horal, M., Chang, T. I., Fortin, G., & Loeken, M. R. (1999). Evidence that elevated glucose causes altered gene expression, apoptosis, and neural tube defects in a mouse model of diabetic pregnancy. DIABETES, 48(12), 2454-2462.

Genotoxicity and diabetic embryopathy: Impaired expression of developmental control genes as a cause of defective morphogenesis
Chang, T. I., & Loeken, M. R. (1999). Genotoxicity and diabetic embryopathy: Impaired expression of developmental control genes as a cause of defective morphogenesis. SEMINARS IN REPRODUCTIVE ENDOCRINOLOGY, 17(2), 153-165.